Carotid endarterectomy for symptomatic carotid stenosis

C S Cina1, C M Clase, R B Haynes

  • 1Department of Surgery, Division of Vascular Surgery, Victoria Medical Centre, Suite 305, 304 Victoria Avenue North, Hamilton, Ontario, Canada, L8N 5G4. cinacs@fhs.csu.mcmaster.ca

Insights

Carotid endarterectomy significantly reduces stroke risk in patients with severe carotid stenosis. However, surgery may increase stroke risk for those with less severe narrowing, emphasizing careful patient selection.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Evidence-Based Medicine

Background:

  • Severe carotid artery stenosis is a major stroke risk factor.
  • Carotid endarterectomy (CEA) can mitigate stroke risk but involves surgical complications.

Purpose of the Study:

  • To review randomized controlled trials on the efficacy and safety of CEA in symptomatic carotid stenosis.
  • To evaluate the risk-benefit balance of CEA versus best medical treatment.

Main Methods:

  • Systematic review of randomized controlled trials comparing CEA plus best medical treatment with best medical treatment alone.
  • Searched Cochrane Stroke Group's Specialized Register and other databases up to March 1999.
  • Intention-to-treat analysis of data from the NASCET and ECST trials.

Main Results:

  • For severe stenosis (ECST > 80% or NASCET > 70%), CEA reduced the relative risk of disabling stroke or death by 48% (NNT = 15).
  • For less severe stenosis (ECST 70-79% or NASCET 50-69%), CEA reduced the relative risk by 27% (NNT = 21).
  • Patients with lesser degrees of stenosis experienced an increased risk of disabling stroke or death (20% increase).

Conclusions:

  • CEA is beneficial for patients with symptomatic carotid stenosis greater than ECST 70% or NASCET 50%.
  • Benefits are limited to surgically-fit patients treated by surgeons with <6% complication rates.
  • CEA may be harmful in patients with less severe stenosis.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...